295 related articles for article (PubMed ID: 24104479)
21. Profiling essential genes in human mammary cells by multiplex RNAi screening.
Silva JM; Marran K; Parker JS; Silva J; Golding M; Schlabach MR; Elledge SJ; Hannon GJ; Chang K
Science; 2008 Feb; 319(5863):617-20. PubMed ID: 18239125
[TBL] [Abstract][Full Text] [Related]
22. PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression.
Wu H; Wang K; Liu W; Hao Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):141-6. PubMed ID: 24434152
[TBL] [Abstract][Full Text] [Related]
23. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
Müller S; Raulefs S; Bruns P; Afonso-Grunz F; Plötner A; Thermann R; Jäger C; Schlitter AM; Kong B; Regel I; Roth WK; Rotter B; Hoffmeier K; Kahl G; Koch I; Theis FJ; Kleeff J; Winter P; Michalski CW
Mol Cancer; 2015 Apr; 14():94. PubMed ID: 25910082
[TBL] [Abstract][Full Text] [Related]
24. Integrative genomic and functional profiling of the pancreatic cancer genome.
Shain AH; Salari K; Giacomini CP; Pollack JR
BMC Genomics; 2013 Sep; 14():624. PubMed ID: 24041470
[TBL] [Abstract][Full Text] [Related]
25. The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy.
Wang Y; Wang Z; Qi Z; Yin S; Zhang N; Liu Y; Liu M; Meng J; Zang R; Zhang Z; Yang G
Mol Cancer; 2014 Apr; 13():94. PubMed ID: 24775809
[TBL] [Abstract][Full Text] [Related]
26. COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines.
Koh JL; Brown KR; Sayad A; Kasimer D; Ketela T; Moffat J
Nucleic Acids Res; 2012 Jan; 40(Database issue):D957-63. PubMed ID: 22102578
[TBL] [Abstract][Full Text] [Related]
27. Differential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancers.
Hsiao TH; Chiu YC; Hsu PY; Lu TP; Lai LC; Tsai MH; Huang TH; Chuang EY; Chen Y
Sci Rep; 2016 Mar; 6():23035. PubMed ID: 26972162
[TBL] [Abstract][Full Text] [Related]
28. The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.
Jones RB; Dorsett KA; Hjelmeland AB; Bellis SL
J Biol Chem; 2018 Apr; 293(15):5659-5667. PubMed ID: 29475939
[TBL] [Abstract][Full Text] [Related]
29. Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.
Yan X; Fraser M; Qiu Q; Tsang BK
Gynecol Oncol; 2006 Aug; 102(2):348-55. PubMed ID: 16545436
[TBL] [Abstract][Full Text] [Related]
30. The butterfly effect in cancer: a single base mutation can remodel the cell.
Hart JR; Zhang Y; Liao L; Ueno L; Du L; Jonkers M; Yates JR; Vogt PK
Proc Natl Acad Sci U S A; 2015 Jan; 112(4):1131-6. PubMed ID: 25583473
[TBL] [Abstract][Full Text] [Related]
31. Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.
Mullany LK; Fan HY; Liu Z; White LD; Marshall A; Gunaratne P; Anderson ML; Creighton CJ; Xin L; Deavers M; Wong KK; Richards JS
Oncogene; 2011 Aug; 30(32):3522-36. PubMed ID: 21423204
[TBL] [Abstract][Full Text] [Related]
32. Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer.
Smith IN; Briggs JM
Proteins; 2016 Nov; 84(11):1625-1643. PubMed ID: 27481051
[TBL] [Abstract][Full Text] [Related]
33. Expression status and mutational analysis of the PTEN and P13K subunit genes in ovarian granulosa cell tumors.
Bittinger S; Alexiadis M; Fuller PJ
Int J Gynecol Cancer; 2009 Apr; 19(3):339-42. PubMed ID: 19407556
[TBL] [Abstract][Full Text] [Related]
34. Cancer network activity associated with therapeutic response and synergism.
Serra-Musach J; Mateo F; Capdevila-Busquets E; de Garibay GR; Zhang X; Guha R; Thomas CJ; Grueso J; Villanueva A; Jaeger S; Heyn H; Vizoso M; Pérez H; Cordero A; Gonzalez-Suarez E; Esteller M; Moreno-Bueno G; Tjärnberg A; Lázaro C; Serra V; Arribas J; Benson M; Gustafsson M; Ferrer M; Aloy P; Pujana MÀ
Genome Med; 2016 Aug; 8(1):88. PubMed ID: 27553366
[TBL] [Abstract][Full Text] [Related]
35. Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer.
Jahchan NS; Ouyang G; Luo K
PLoS One; 2013; 8(2):e55794. PubMed ID: 23418461
[TBL] [Abstract][Full Text] [Related]
36. Expression analysis of mammaglobin A (SCGB2A2) and lipophilin B (SCGB1D2) in more than 300 human tumors and matching normal tissues reveals their co-expression in gynecologic malignancies.
Zafrakas M; Petschke B; Donner A; Fritzsche F; Kristiansen G; Knüchel R; Dahl E
BMC Cancer; 2006 Apr; 6():88. PubMed ID: 16603086
[TBL] [Abstract][Full Text] [Related]
37. Common Genomic Aberrations in Mouse and Human Breast Cancers with Concurrent P53 Deficiency and Activated PTEN-PI3K-AKT Pathway.
Martinez JD; Mo Q; Xu Y; Qin L; Li Y; Xu J
Int J Biol Sci; 2022; 18(1):229-241. PubMed ID: 34975329
[TBL] [Abstract][Full Text] [Related]
38. PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma.
Zeleniak AE; Huang W; Fishel ML; Hill R
Neoplasia; 2018 Jan; 20(1):12-24. PubMed ID: 29175021
[TBL] [Abstract][Full Text] [Related]
39. Beyond BRCA1 and BRCA2 wild-type breast and/or ovarian cancer families: germline mutations in TP53 and PTEN.
Blanco A; Graña B; Fachal L; Santamariña M; Cameselle-Teijeiro J; Ruíz-Ponte C; Carracedo A; Vega A
Clin Genet; 2010 Feb; 77(2):193-6. PubMed ID: 19930417
[No Abstract] [Full Text] [Related]
40. Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer.
Jeong HH; Leem S; Wee K; Sohn KA
J Ovarian Res; 2015 Jul; 8():42. PubMed ID: 26138921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
